Publikationen, an denen er mitarbeitet ELIECER COTO GARCIA (124)

2024

  1. Chromosome-Y haplogroups in Asturias (Northern Spain) and their association with severe COVID-19

    Molecular Genetics and Genomics, Vol. 299, Núm. 1

  2. Identification of host endotypes using peripheral blood transcriptomics in a prospective cohort of patients with endocarditis

    International Journal of Infectious Diseases, Vol. 148

  3. Immunoglobulin genes and severity of COVID-19

    Immunogenetics, Vol. 76, Núm. 3, pp. 213-217

  4. PCSK9 gene variations in the clinical setting of premature cardiovascular disease: A critical appraisal

    International Journal of Cardiology, Vol. 413

  5. Retrospective variant reclassification and resequencing in hypertrophic cardiomyopathy: a reference unit centre experience

    European Journal of Preventive Cardiology, Vol. 31, Núm. 6, pp. e38-e41

  6. Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing

    International Journal of Cardiology, Vol. 408

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Age-dependent effect of the IFIH1/MDA5 gene variants on the risk of critical COVID-19

    Immunogenetics, Vol. 75, Núm. 2, pp. 91-98

  3. Chromosome Y Haplogroup R Was Associated with the Risk of Premature Myocardial Infarction with ST-Elevation: Data from the CholeSTEMI Registry

    Journal of Clinical Medicine, Vol. 12, Núm. 14

  4. Clinical Evaluation of Patients with Genetically Confirmed Familial Hypercholesterolemia

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  5. Mitochondrial Heteroplasmy as a Marker for Premature Coronary Artery Disease: Analysis of the Poly-C Tract of the Control Region Sequence

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  6. Opportunistic Genetic Screening for Familial Hypercholesterolemia in Heart Transplant Patients

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  7. Transcriptomic clustering of critically ill COVID-19 patients

    The European respiratory journal, Vol. 61, Núm. 1

2022

  1. A first update on mapping the human genetic architecture of COVID-19

    Nature

  2. Association of the Genetic Variation in the Long Non‐Coding RNA FENDRR with the Risk of Developing Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 6

  3. Common mitochondrial haplogroups as modifiers of the onset-age for critical COVID-19

    Mitochondrion, Vol. 67, pp. 1-5

  4. Different Phenotypes in Monozygotic Twins, Carriers of the Same Pathogenic Variant for Hypertrophic Cardiomyopathy

    Life, Vol. 12, Núm. 9

  5. Effects of IFIH1 rs1990760 variants on systemic inflammation and outcome in critically ill COVID-19 patients in an observational translational study

    eLife, Vol. 11

  6. FURIN gene variants (rs6224/rs4702) as potential markers of death and cardiovascular traits in severe COVID-19

    Journal of Medical Virology, Vol. 94, Núm. 8, pp. 3589-3595

  7. Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients

    Human Immunology, Vol. 83, Núm. 8-9, pp. 613-617